Sign In

Co-Occurring Conditions.

HIV Question Bank

Hepatitis C CoinfectionQuestion 4/10

Questions in Topic

A 48-year-old transgender man with HIV has coinfection with hepatitis C virus (HCV). Laboratory studies show a CD4 count of 623 cells/mm3, an undetectable HIV RNA level, and an HCV RNA level of 7 million IU/mL. Noninvasive evaluation of liver fibrosis indicates that he does not have cirrhosis. He has never received therapy for HCV and is scheduled to start treatment for HCV at the next visit.

When treating HCV in this patient with HIV using a recommended pangenotypic oral regimen, what is the expected likelihood of achieving a sustained virologic response at 12 weeks (SVR12)?

Prev  Skip

Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Question Last Updated
September 29th, 2023

Steps to Acquire CE for this Question Bank Topic:

1

Answer

Answer all questions
2

Score 80%+

Answer correctly
3

Claim CE

Choose CNE or CME
4

Give Feedback

Complete survey
5

Print Certificate

Obtain proof of CE

This question requires improvement because:


Comment further on how to improve this question or summary:



Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.